Abstract
Hepatitis C virus (HCV) is the major etiologic agent of parenterally transmitted non-A,non-B hepatitis. To determine whether there is a relationship between this virus agent and hepatocellular carcinoma (HCC), the sera of patients with HCC and chronic hepatitis were assessed using a sensitive immunoassay for HCV antibody. Anti-HCV was detected in 65% of 132 patients with HCC, without any relationship with the presence of the hepatitis B surface antigen (HBsAg). The prevalence (74%) of anti-HCV was high, as expected in patients with putative non-A,non-B cirrhosis also. The prevalence of anti-HCV was less in patients with HBsAg-positive cirrhosis (28%) and in patients with disease not related to viral hepatitis and healthy controls (8%). These data suggest, but do not prove, that HCV is an important factor associated with HCC.
References
Perkin DM, Stjernsward J, Muir CS: Estimates of the worldwide frequency of twelve major cancers. Bull Med Health Org 62:163–182, 1984
Waterhouse JAM, Muir C, Shaurragaratnem K, Powell J: Cancer Incidence in Five Continents, Vol IV. Lyon, International Agency for Research on Cancer (IARC Scientific Publications N 42), 1982
Di Bisceglie A, Tustgi VK, Hoofnagle JH, Dusheiko GM, Lotre MT: NIH conference: Hepatocellular carcinoma. Ann Int Med 108:390–401, 1988
Johnson PJ, Williams R: Cirrhosis and the etiology of hepatocellular carcinoma. J Hepatol 4:140–147, 1987
Villa E, Baldini GM, Pasquinelli C, Melegari M, Cariani E, Di Chirico G, Manenti F: Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A,non-B infection and alcohol. Cancer 62:611–615, 1988
La Vecchia C, Negri E, De Carli A, D'Avanzo B, Franceschi S: Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 42:872–876, 1988
Tabor E: Hepatocellular carcinoma: Possible etiologies in patients without serologic evidence of hepatitis B virus infection. J Med Virol 27:1–6, 1989
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A,non-B viral hepatitis genome. Science 244:359–361, 1989
Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M: An assay for circulating antibodies to a major etiologic virus of human non-A,non-B hepatitis. Science 244:362–364, 1989
Baldi A, Olivieri F, Kuo G, et al: Antibody to hepatitis C Virus in the serum of patients with chronic hepatitis. 1st International Meeting on Hepatitis C virus. Rome, September 14–15, 1989 (abstract)
Esteban JI, Esteban R, Viladonim L, et al: Hepatitis C virus antibodies among risk groups in Spain. Lancet 2:294–297, 1989
Van der Poel CL, Reesnik HW, Lelie PN, et al: Antihepatitis C antibodies and non-A,non-B post transfusion hepatitis in the Netherlands. Lancet 2:297–299, 1989
Bruix J, Barrera JM, Calvet X, et al: Prevalence of anti-hepatitis C virus antibodies in hepatocellular carcinoma and liver cirrhosis in Spain. 1st International Meeting on Hepatitis C virus. Rome, September 14–15, 1989 (abstract)
Trepo C, Pichoud C, Zoulim F, et al: Prevalence of anti-HCV in chronic liver diseases in France: correlation with anti-HBc. 1st International Meeting on Hepatitis C virus. Rome, September 14–15, 1989 (abstract)
Grossi A, Tagger A, Ribero ML, Pregliasco F, Pasquali ML, Salvaneschi S, Ferroni P: Antibody to hepatitis C virus in blood donors. 1st International Meeting on Hepatitis C virus. Rome, September 14–15, 1989 (abstract)
Zuckerman AJ: Viral superinfection. Hepatology 7:184–185, 1987
Hoofnagle JH: Serodiagnosis of acute viral hepatitis. Hepatology 2:267–268, 1983 (editorial)
Dienstag JL, Alter HJ: Non-A,non-B hepatitis: Evolving epidemiologic and clinical perspectives. Semin Liver Dis 6:67–81, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Colombo, M., Rumi, M.G., Donato, M.F. et al. Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma. Digest Dis Sci 36, 1130–1133 (1991). https://doi.org/10.1007/BF01297459
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01297459